Further Enquiries

School of Molecular & Biomedical Science
The University of Adelaide
AUSTRALIA 5005

Contact:
Dr David Ellis
Email

Telephone:
+61 8 8161 6459
Facsimile:
+61 8 8161 7589

Guidelines for Antifungal Therapy

Download the the following pdf files:

ASID Australian Antifungal Guidelines Updated 2008

Published in Internal Medicine Journal 38 (2008) 457-541

Introduction to the updated Australian and New Zealand consensus guidelines for the use of antifungal agents in the haematology/oncology setting, 2008. (Internal Medicine Journal 38:2008:457–467)

Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. (Internal Medicine Journal 38:2008:468–476)

Diagnostic and therapeutic approach to persistent or recurrent fevers of unknown origin in adult stem cell transplantation and haematological malignancy. (Internal Medicine Journal 38:2008:477–495)

Recommendations for the treatment of established fungal infections. (Internal Medicine Journal 38:2008:496–520)

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders. (Internal Medicine Journal 38:2008:521–537)

Preventing invasive fungal infection during hospital building works. (Internal Medicine Journal 38:2008:538–541)

Australasian guidelines for antifungal therapy in neonates and children with proven, probable and suspected fungal infections.

European Expert Opinion on the Management of Invasive Candidiasis in Adults

Management of Invasive Candidiasis in Adults (Clinical Microbiology and Infection 2011, 17, supplement 5)

IDSA Practice Guidelines for the Treatment of Fungal Infection

Website: www.idsociety.org

Published in Clinical Infectious Diseases

Guidelines Introduction 2000 (CID 2000;30:652)

Antifungal agents 2000 (CID 2000;30:653–7)

Aspergillosis 2008 (CID 2008;46:327–360)

Blastomycosis 2008 (CID 2008;46:1801–1812)

Candidiasis 2009 (CID 2009;48:503–535

Coccidioidomycosis 2008 (CID 2005;41:1217–1223)

Cryptococcosis 2010 (CID 2010;50:291-322)

Histoplasmosis 2007 (CID 2007;45:807–25)

Sporotrichosis 2007 (CID 2007; 5:1255–65)

The ECIL 1 Antifungal Guidelines (First European Conference on Infections in Leukemia)

The ECIL-1 is a common initiative of the following groups or organisations: Infectious Diseases Working Party of the European Blood and Marrow Transplantation Group (EBMT-IDWP), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (EORTC-IDG), European Leukemia Net (ELN) (EU Grant No.: LSHC-CT-2004), and International Immunocompromised Host Society (ICHS).

Empirical antifungal therapy in neutropaenic cancer patients with persistent fever (EJC Supplement S5:2007:32-42)

Primary antifungal prophylaxis in leukaemia patients (EJC Supplement S5:2007:43-48)

Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients (EJC Supplement S5:2007:49-59)

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update (Bone Marrow Transplantation 2011, 46:709-718)